Back to BlackRock, Inc. BlackRock, Inc.

RPRXRPRX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ROYALTY PHARMA PLC

BlackRock, Inc. holds 27.8M shares of RPRX (ROYALTY PHARMA PLC), worth $1.6B as of 2026-Q2. The position was increased (+7.4% shares). RPRX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$1.6B

Current Shares

27.8M

Total Value Change

+$911.5M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
27.8M
+7.4%
$1.6B0.0%$55.85
34
2026-Q1
Decreased
25.9M
-1.1%
$1.2B0.0%$47.57
0
2025-Q4
Decreased
26.2M
-0.1%
$1B0.0%$38.12
0
2025-Q3
Increased
26.2M
+3.0%
$924.4M0.0%$34.61
33
2025-Q2
Increased
25.4M
+3.6%
$916.2M0.0%$35.13
33
2025-Q1
Decreased
24.6M
-3.5%
$764.4M0.0%$30.15
0
2024-Q4
New
25.4M
-
$649.1M0.0%$24.55
44

Other major holders of RPRX: MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used